BarringerB. S., WoodardH. Q.: Prostatic carcinoma with extensive intraprostatic calcification. With discussion of the possible role of prostatic phosphatase. Trans. amer. Ass. genito-urin. Surg., 31; 363–369 (1938).
2.
BodanskyM., BodanskyO.: Biochemistry of disease. 2nd. ed. MacMillan Co. Ltd., New York1952.
3.
BonnerC. D., HomburgerF., FishmanW. F.: Some factors other than neoplasms altering the prostatic fraction of acid phosphatase in the serum. Surg., Gynec. & Obst., 99; 179–183 (1954).
4.
BrodersA. C.: Epithelioma of genitourinary organs. Ann. Surg., 75; 574–584 (1922).
5.
DowD., WhitakerR.: Prostatic contribution to normal serum acid phosphatase. Brit. med. J., 4; 470–472 (1970).
6.
FishmanW. H., DartR. M., BonnerC. D., LeadbetterW. F., LernerF., HomburgerF.: A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate. J. clin. Invest., 32; 1034–1044 (1953).
7.
FishmanW. H., DavidsonH. M., BonnerC. D., HomburgerF.: Studies on prostatic acid phosphatase and cancer of the prostate. Cancer Res., 2; 105–112 (1956).
8.
FraleyE. E., HowardP. J.jr.: Serum prostatic acid phosphatase in cancer of the prostate. Surg. Forum, 17; 519–520 (1966).
9.
GravesR. C., DesautelsR. E., WarrenS.: Hormone-independent cancer of the prostate. J. Urol., 79; 324–331 (1958).
10.
GutmanA. B., GutmanE. B.: An acid phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostatic gland. J. clin. Invest., 17; 473–483 (1938).
11.
HockE., TessierR. N.: Elevation of serum acid phosphatase following prostatic massage. J. Urol., 62; 488–494 (1949).
12.
HugginsC., HodgesC. V.: Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res., 1; 293–297 (1941).
13.
Iatron: Technical Bulletin ACP-S, Sanko-Junyaku Co. Ltd., Tokyo 1970.
14.
LethamH. S.: Acid phosphatase: any value in prostatic carcinoma? Va. med. Mon., 98; 47–49 (1971).
15.
MurphyG. P., ReynosoG., KennyG. M., GaetaJ. F.: Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma. Cancer, 23; 1309–1314 (1969).
16.
MusteaI.: Modifications de l'activité de la transaminase glutamique-oxalacétique sérique dans le diagnostic différentiel des processus néoplastiques. Clin. Chim. Acta, 22; 201–206 (1968).
17.
NesbitR. M., BaumW. C.: Serum phosphatase determinations in diagnosis of prostatic cancer. J. amer. med. Ass., 145; 1321–1323 (1951).
18.
OchiaiR., TakeuchiH.: Acid phosphatase: how to read its figures. Jap. J. clin. Med., 29; 688–695 (1971).
19.
PerrinJ., MalleinR., ArchimbaudJ. P., BoucheratM.: Valeur du dosage de la phosphatase acide du sérum dans le diagnostic et le pronostic des affections prostatiques. Comparaisons des résultats obtenus avec le technique de King et Jegatheesan et la technique de Babson et Read. Presse méd., 75; 1985–1968 (1967).
20.
ProutG. R.: Chemical tests in the diagnosis of prostatic carcinoma. J. amer. med. Ass., 209; 1699–1700 (1969).
SuillivanT. J., GutmanE. B., GutmanA. B.: Theory and application of the serum acid phosphatase determination in metastasizing prostatic carcinoma; early effects of castration. J. Urol., 48; 426–458 (1942).
23.
WhitmoreW. F.jr., BodanskyO., SchwartzM. K., YingS. H., DayE.: Serum prostatic acid phosphatase levels in proved cases of carcinoma or benign hypertrophy of prostate. Cancer, 9; 228–233 (1956).
24.
WoodardH. Q.: Factors leading to elevations in serum acid glycerophosphatase. Cancer, 5; 236–241 (1952).
25.
WoodardH. Q.: The clinical significance of serum acid phosphatase. Amer. J. Med., 27; 902–910 (1959).
26.
WarburgO., PosenerK., NegeleinE.: Ueber den Stoffwechsel der Carcinomzelle. Biochem. Z., 152; 309–344 (1924).